Serotype specific epitopes identified by neutralizing antibodies underpin immunogenic differences in Enterovirus B
Kang Wang(Fujian Medical University), Xiangxi Wang(Peking University), Zhenxi Guo(Peking University), Yu Guo(Nankai University), Zihe Rao(Nankai University), Ling Zhu(Institute of Genetics), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Binyang Zheng(Chinese Academy of Sciences), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Li Zhang(Beijing Red Cross Blood Center), Wei Zhang(Nankai University), Qian Zhang(Nankai University), Xuan Su(Augusta University)
Cited by 32
Related Papers
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
|The Lancet Infectious Diseases|2020|1.5k
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
Versatile applications of capacitive deionization (CDI)-based technologies
|Desalination|2020|316
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268